ARHGAP24 inhibits cell cycle progression, induces apoptosis and suppresses invasion in renal cell carcinoma

被引:35
作者
Xu, Gaosi [1 ]
Lu, Xiongbing [2 ]
Huang, Tianlun [1 ]
Fan, Jie [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Nephrol, Nanchang, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 2, Dept Urol, Nanchang, Peoples R China
关键词
renal cancer; ARHGAP24; proliferation; cell cycle; apoptosis; GTPASE-ACTIVATING PROTEIN; RHO GTPASES; FILGAP; RAC; IDENTIFICATION; KINASE; GAP;
D O I
10.18632/oncotarget.10386
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Renal cell carcinoma (RCC) is the major cause of kidney malignancy-related deaths. Rho GTPases are key regulators in cancer cell metastasis. ARHGAP24, a Racspecific member of the Rho GTPase-activating protein family, acts as a functional target of cancer cell migration and invasion. In the present study, we identified ARHGAP24 expression is downregulated in renal cancer tissues and is highly correlated with long-term survival in RCC patients. Therefore, we investigated the biological functions of ARHGAP24 in renal cancer cells. Ectopic expression of ARHGAP24 resulted in inhibited cell proliferation and arrested cell cycle in two renal cancer cell lines (786-0 and Caki-2); the results were confirmed by ARHGAP24 knocking down. In addition, ARHGAP24 significantly reduced the cell invasion ability and induced apoptosis in renal cancer cells. In addition, overexpressing ARHGAP24 impaired tumor formation in vivo. In summary, our results illustrated that ARHGAP24 plays a unique role in RCC progression as a tumor repressor.
引用
收藏
页码:51829 / 51839
页数:11
相关论文
共 31 条
[1]   Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis [J].
Akilesh, Shreeram ;
Suleiman, Hani ;
Yu, Haiyang ;
Stander, M. Christine ;
Lavin, Peter ;
Gbadegesin, Rasheed ;
Antignac, Corinne ;
Pollak, Martin ;
Kopp, Jeffrey B. ;
Winn, Michelle P. ;
Shaw, Andrey S. .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (10) :4127-4137
[2]   Genomic analysis as the first step toward personalized treatment in renal cell carcinoma [J].
Bielecka, Zofia Felicia ;
Czarnecka, Anna Malgorzata ;
Szczylik, Cezary .
FRONTIERS IN ONCOLOGY, 2014, 4
[3]   GEFs and GAPs: Critical elements in the control of small G proteins [J].
Bos, Johannes L. ;
Rehmann, Holger ;
Wittinghofer, Alfred .
CELL, 2007, 129 (05) :865-877
[4]   Rho regulation: DLC proteins in space and time [J].
Braun, Anja C. ;
Olayioye, Monilola A. .
CELLULAR SIGNALLING, 2015, 27 (08) :1643-1651
[5]  
CHEN F, 2016, CELL REP
[6]   Jade-1 inhibits Wnt signalling by ubiquitylating β-catenin and mediates Wnt pathway inhibition by pVHL [J].
Chitalia, Vipul C. ;
Foy, Rebecca L. ;
Bachschmid, Markus M. ;
Zeng, Liling ;
Panchenko, Maria V. ;
Zhou, Mina I. ;
Bharti, Ajit ;
Seldin, David C. ;
Lecker, Stewart H. ;
Dominguez, Isabel ;
Cohen, Herbert T. .
NATURE CELL BIOLOGY, 2008, 10 (10) :1208-1216
[7]   Targeted therapy for advanced renal cell carcinoma [J].
Coppin, C. ;
Le, L. ;
Porzsolt, F. ;
Wilt, T. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02)
[8]   Renal cell carcinoma: Current status and future prospects [J].
Drucker, BJ .
CANCER TREATMENT REVIEWS, 2005, 31 (07) :536-545
[9]   RASAL2 activates RAC1 to promote triple-negative breast cancer progression [J].
Feng, Min F ;
Bao, Yi ;
Li, Zhimei ;
Li, Juntao ;
Gong, Min ;
Lam, Stella ;
Wang, Jinhua ;
Marzese, Diego M. ;
Donovan, Nicholas ;
Tan, Ern Yu ;
Hoon, Dave S. B. ;
Yu, Qiang .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (12) :5291-5304
[10]   Interstitial leukocyte migration and immune function [J].
Friedl, Peter ;
Weigelin, Bettina .
NATURE IMMUNOLOGY, 2008, 9 (09) :960-969